Products
-
Top 10 Medications and Their Ocular Side Effects - COPE 93780-PH (1 HRS)
CourseExpires 2027-09-26, Activity ID 129410, COPE 93780-PH (1 Hour) Patients present taking a variety of medications, both topical and systemic. This interactive presentation will review the top 10 medications patients take and review the ocular side ...
$25
-
My Vision Is Blurry: Could It Be From My Medications? - COPE 87218-PH (2 HRS)
CourseExpires 2026-09-20, Activity ID 127000, COPE 87218-PH (2 Hours) This course will review ophthalmic complications related to systemic medications. Ocular toxicities will include hydroxychloroquine, ethambutol, alendronate, sildenafil and more. The ...
$50
-
Contemporary Prescribing of Oral Pharmaceuticals in Eye Disease - COPE 87109-PH (1 HRS)
CourseExpires 2026-09-14, Activity ID 127000, COPE 87109-PH (1 Hour) This course presents the contemporary management of systemically administered medications used to treat eye disease. Clinical application of prescribing indications, potential adverse ...
$25
-
Top Ten Medications in Eye Care for 2022 - COPE 78235-PH (1 Hours)
CourseExpires 2025-04-05, Activity ID 125303, COPE 78235-PH (1 Hours) This course will discuss the most common ophthalmic prescriptions that eye care providers of 2022 need to know. We will discuss both oral and topical ophthalmic therapeutics for a variet
$25
-
Opioid and Endocannabinoid Education - Prescribing for Pain: Optometry - COPE 77840-PH (1 Hours)
CourseExpires 2025-03-28, Activity ID 123785, COPE 77840-PH (1 Hours) This course will provide the optometrist with the information needed in prescribing opioid medications/cannabinoids safely in their office. It will review anatomical pain pathways, opioi
$25
-
Marijuana, Cannabis, Cannabinoids Glaucoma and IOP - COPE 79258-PH (1 Hours)
CourseExpires 2025-04-25, Activity ID 125303, COPE 79258-PH (1 Hours) This lecture will review the research related to cannabinoids and marijuana and their use in the treatment of glaucoma. This lecture will also review how CBD is being used in FDA approve
$25